SENSEX NIFTY
Dec 09, 2012, 08.26 PM IST | Source: PTI

Ind-Swift Labs aims to touch Rs 1500cr turnover by 2015

Drug firm Ind-Swift Laboratories has set a target of achieving revenues of Rs 1,500 crore by 2015 with overseas markets like Japan, the European Union and the United States being the main growth drivers.

Drug firm Ind-Swift Laboratories has set a target of achieving revenues of Rs 1,500 crore by 2015 with overseas markets like Japan, the European Union and the United States being the main growth drivers.

"We expect to achieve revenues of Rs 1,500 crore by 2015. European Union, Japan, Australia and US will be the main drivers of growth for future," Ind-Swift Laboratories Vice Chairman cum Managing Director NR Munjal told PTI.

Ind-Swift Laboratories is currently witnessing 15 per cent to 20 per cent growth, he added.

"The current revenues of the company at present stand at over Rs 1,000 crore," Munjal said.

The main focus of the business for Ind-Swift laboratories continues to be its active pharmaceuticals Ingredients (API) business, he added.

Established in 1995, Ind-Swift's business model is focussed on domestic market and high-value mature regulated markets along with considerable focus on the emerging markets as well.

The accreditations of the company's facilities from the US Food and Drug Administration (USFDA) for five products and Pharmaceuticals and Medical Devices Agency (PMDA), Japan for two products have boosted the efforts to tap these highly regulated markets for products, the company said.

In July this year, the company forayed in the contract research and manufacturing services (CRAMS) segment and received the first order from a European pharmaceutical company.

"The order is for developing a non-infringing process for a anti-diabetes molecule that is going off patent in next three to four years," a spokesperson of the Chandigarh based firm had then said.

The Chandigarh based drug firm has manufacturing sites at six different locations across India.

Ind-Swift stock price

On October 20, 2014, Ind-Swift closed at Rs 7.94, down Rs 0.36, or 4.34 percent. The 52-week high of the share was Rs 12.88 and the 52-week low was Rs 5.14.


The latest book value of the company is Rs 17.38 per share. At current value, the price-to-book value of the company was 0.46.

READ MORE ON  Ind-Swift Laboratories
Set email alert for

ADS BY GOOGLE

video of the day

Indian economy to see real turnaround in 6 mths: Madhu Kela

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.